Cinco décadas de cineclubismo en la UAEM. Relato narrativo testimonial. Alcances y perspectivas

Precedido de un acercamiento conceptual al cine como fenómeno sociocultural que, desde su origen y a lo largo de su desarrollo, ha permeado, de distintas maneras, en los diferentes estratos sociales, al punto de llegar a convertirse en una poderosa e influyente industria-mercancía de “consumo” cotidiano, el testimonio que nos ofrecen los autores de este relato es producto de un trabajo de investigación sobre la actividad cineclubista que desde hace cincuenta años se ha llevado a cabo en nuestra máxima casa de estudios; incluye unas entrevistas a los cinecluberos protagonistas y a algunos de los más asiduos cinéfilos, quienes, en voz propia, contribuyen a testimoniar la significativa labor que, como alternativa del cine comercial, ha tenido el Cineclub de la UAEM para promover y difundir, entre la comunidad universitaria y a la sociedad en general, la cultura cinematográfica

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

Porcentaje de concepción en vacas lecheras tratadas con progesterona cinco días después de la inseminación

El incremento temporal de las concentraciones séricas de progesterona entre los días cinco y nueve posinseminación favorece el crecimiento del embrión y la secreción de Interferón-t. En este estudio se probó si una inyección de progesterona en el día cinco posinseminación incrementa el porcentaje de concepción (PC) en vacas lecheras. Se utilizaron 561 vacas de primero y segundo servicios. Las vacas se observaron en estro y se inseminaron bajo el programa “am-pm/pm-am”. Cinco días después, se asignaron al azar a dos tratamientos: P4 (n= 282), recibieron 500 mg de progesterona i.m.; Testigo (n= 279), no recibieron progesterona. El diagnóstico de gestación se hizo mediante palpación rectal entre 45 y 50 días posinseminación. Para caracterizar el perfil sanguíneo de progesterona, cinco vacas no inseminadas que tuvieron un cuerpo lúteo recibieron dos inyecciones de PGF2a con 24 h de diferencia; posteriormente, recibieron 500 mg de progesterona vía i.m. y se determinaron las concentraciones de progesterona diariamente durante seis días. No hubo diferencia (P>0.10) en el PC entre el grupo P4 (44 %) y el testigo (41 %). Las vacas tratadas con progesterona que retornaron al estro mostraron un PC mayor (P<0.05) que las vacas del grupo testigo (P4= 45 %; 31/69 vs testigo= 31 %; 31/99). Las concentraciones de progesterona fueron mayores de 1 ng/ml entre 48 y 72 h postratamiento. Se concluye que la administración de progesterona cinco días después dela inseminación no afectó el PC; sin embargo, este tratamiento incrementó el porcentaje de concepción en el ciclo subsiguiente

Multidisciplina y estrategias metodológicas en las Ciencias Sociales

El libro integra trabajos multidisciplinarios con base en las líneas de investigación de Educación y Cultura, Sociología, Comunicación, Administración Pública y Ciencia Política. Se abordan diversos temas, como el papel de las redes sociales, el imaginario social del cuerpo femenino desde la perspectiva de las mismas mujeres, alcances del gobierno electrónico, la adopción de menores en México, el rol de las mujeres en grupos indígenas otomíes del Estado de México y el clientelismo electoral

Role of age and comorbidities in mortality of patients with infective endocarditis.

The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups: A total of 3120 patients with IE (1327  There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in th

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN